Qisda Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Peter Chen

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	10.8yrs
Participación del CEO	0.08%
Permanencia media de la dirección	2.7yrs
Promedio de permanencia en la Junta Directiva	4.4yrs

Actualizaciones recientes de la dirección

Recent updates

Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 12

Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Mar 09

Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt

Feb 29

Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?

Mar 15

Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Feb 26

These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well

Feb 08

Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?

Jan 24

Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment

Jan 09

We Like These Underlying Trends At Qisda (TPE:2352)

Dec 25

Qisda Corporation (TPE:2352) Is Yielding 2.8% - But Is It A Buy?

Dec 05

Qisda Corporation (TPE:2352) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Nov 20

CEO

Peter Chen (63 yo)

10.8yrs

Permanencia

Mr. Chi-Hong Chen, also known as Peter, serves as the Chairman of BenQ Medical Technology Corporation since April 2010. Mr. Chen serves as the Chairman and Director of DFI Inc. Mr. Chen had been the Presid...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Chi-Hong Chen	CEO & Chairman	no data	sin datos	0.079% NT$ 56.9m
Han-Chou Huang	President & Director	2.6yrs	sin datos	0.030% NT$ 21.3m
Chiu-Chin Hung	VP, CFO & Accounting Officer	no data	sin datos	0.030% NT$ 21.6m
Ta-Wen Liou	Chief Accountant	5.2yrs	sin datos	sin datos
Danny Lin	VP and Chief HR	2.8yrs	sin datos	0.0080% NT$ 5.7m
Wen-Fang Huang	President of the Network Communication Business Unit	less than a year	sin datos	sin datos
Harry Yang	VP & President of the Medical Devices Products Group	no data	sin datos	sin datos
Eric Lee	GM of Manufacturing Operations & MD of Qisda China	less than a year	sin datos	sin datos
L.. S. Wang	CIO	no data	sin datos	sin datos
Li-Wen Huang	Chief Information Security Officer	4.7yrs	sin datos	sin datos

2.7yrs

Permanencia media

Equipo directivo experimentado: El equipo directivo de 2352 se considera experimentado (2.7 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Chi-Hong Chen	CEO & Chairman	10.8yrs	sin datos	0.079% NT$ 56.9m
Han-Chou Huang	President & Director	7.4yrs	sin datos	0.030% NT$ 21.3m
Shuang-Lang Peng	Director	14.4yrs	sin datos	0.0038% NT$ 2.8m
Chien-Pin Chen	Director	1.5yrs	sin datos	0.000030% NT$ 21.6k
Lo-Yu Yen	Independent Director	4.4yrs	sin datos	sin datos
Jyuo-Min Shyu	Independent Director	4.4yrs	sin datos	sin datos
Liang-Gee Chen	Independent Director	1.5yrs	sin datos	sin datos
Chiu-Lien Lin	Independent Director	1.5yrs	sin datos	sin datos
Shu-Chun Huang	Independent Director	1.5yrs	sin datos	sin datos

4.4yrs

Permanencia media

64yo

Promedio de edad

Junta con experiencia: La junta directiva de 2352 se considera experimentada (4.4 años de antigüedad promedio).

Qisda Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Qisda Corporation, Annual General Meeting, May 29, 2024

Qisda Corporation Announces Board Appointments

Qisda Corporation Announces Board Elections

Qisda Corporation Announces Executive Changes

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Qisda Corporation (TWSE:2352) completed the acquisition of an additional 13.95% stake in Norbel Baby Co., Ltd (TPEX:6844).

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Consensus EPS estimates fall by 17%

Qisda Corporation to Report Q3, 2024 Results on Nov 05, 2024

Qisda Corporation (TWSE:2352) proposed to acquire an additional 13.95% stake in Norbel Baby Co., Ltd (TPEX:6844) for approximately TWD 910 million.

Consensus EPS estimates fall by 17%

Price target decreased by 7.9% to NT$40.77

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Qisda Corporation to Report Q2, 2024 Results on Aug 06, 2024

Dividend reduced to NT$1.20

New major risk - Financial position

First quarter 2024 earnings released: EPS: NT$0.13 (vs NT$0.17 in 1Q 2023)

Qisda Corporation to Report Q1, 2024 Results on May 07, 2024

Qisda's (TWSE:2352) Weak Earnings May Only Reveal A Part Of The Whole Picture

Consensus EPS estimates fall by 18%

Qisda Corporation Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

Price target decreased by 22% to NT$42.00

Full year 2023 earnings: EPS misses analyst expectations

Qisda Corporation, Annual General Meeting, May 29, 2024

Qisda (TWSE:2352) Takes On Some Risk With Its Use Of Debt

Consensus EPS estimates fall by 15%

Qisda Corporation Provides Revenue Forecast for the Year 2023

Consensus EPS estimates fall by 12%

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Qisda Corporation Announces Board Appointments

New minor risk - Share price stability

Investor sentiment improves as stock rises 17%

Upcoming dividend of NT$2.00 per share at 4.0% yield

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Qisda Corporation Announces Cash Dividend, Payable on August 18, 2023

Investor sentiment improves as stock rises 15%

New minor risk - Earnings quality

Qisda Corporation Announces Board Elections

Qisda Corporation Announces Executive Changes

Full year 2022 earnings: EPS misses analyst expectations

Less than half of directors are independent

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Price target decreased to NT$29.55

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Consensus forecasts updated

Upcoming dividend of NT$2.50 per share

Qisda Corporation Announces Cash Dividend, Payable on 25 August 2022

Consensus forecasts updated

Price target decreased to NT$32.25

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Qisda Corporation Announces Dividend for the Year December 31, 2021

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Upcoming dividend of NT$1.50 per share

First quarter 2021 earnings released: EPS NT$1.07 (vs NT$0.12 in 1Q 2020)

Investor sentiment deteriorated over the past week

Consensus EPS estimates increase to NT$3.84

Price target increased to NT$33.50

Qisda Corporation announced a financing transaction

Full year 2020 earnings released: EPS NT$2.54 (vs NT$1.82 in FY 2019)

Is Qisda Corporation (TPE:2352) A Smart Pick For Income Investors?

Qisda Corporation's (TPE:2352) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

New 90-day high: NT$30.20

These 4 Measures Indicate That Qisda (TPE:2352) Is Using Debt Reasonably Well

New 90-day high: NT$29.70

Should You Use Qisda's (TPE:2352) Statutory Earnings To Analyse It?

Qisda (TPE:2352) Has Gifted Shareholders With A Fantastic 275% Total Return On Their Investment

New 90-day high: NT$29.30

We Like These Underlying Trends At Qisda (TPE:2352)

New 90-day high: NT$27.45

Qisda Corporation (TPE:2352) Is Yielding 2.8% - But Is It A Buy?

Market bids up stock over the past week

Qisda Corporation (TPE:2352) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?

Third quarter 2020 earnings released: EPS NT$1.04